ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 231 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $374,000 | +78.1% | 4,020 | +14.2% | 0.04% | +66.7% |
| Q3 2021 | $210,000 | -12.5% | 3,520 | 0.0% | 0.03% | -15.6% |
| Q2 2021 | $240,000 | -1.6% | 3,520 | 0.0% | 0.03% | -11.1% |
| Q1 2021 | $244,000 | -9.6% | 3,520 | 0.0% | 0.04% | -16.3% |
| Q4 2020 | $270,000 | +2.7% | 3,520 | 0.0% | 0.04% | -6.5% |
| Q3 2020 | $263,000 | +18.5% | 3,520 | 0.0% | 0.05% | +9.5% |
| Q2 2020 | $222,000 | +50.0% | 3,520 | 0.0% | 0.04% | +31.2% |
| Q1 2020 | $148,000 | -7.5% | 3,520 | 0.0% | 0.03% | +10.3% |
| Q4 2019 | $160,000 | -0.6% | 3,520 | 0.0% | 0.03% | -9.4% |
| Q3 2019 | $161,000 | -21.8% | 3,520 | 0.0% | 0.03% | -23.8% |
| Q2 2019 | $206,000 | +30.4% | 3,520 | 0.0% | 0.04% | +5.0% |
| Q1 2019 | $158,000 | +16.2% | 3,520 | +0.6% | 0.04% | +8.1% |
| Q4 2018 | $136,000 | -15.5% | 3,500 | 0.0% | 0.04% | -14.0% |
| Q3 2018 | $161,000 | +5.2% | 3,500 | 0.0% | 0.04% | -2.3% |
| Q2 2018 | $153,000 | +23.4% | 3,500 | 0.0% | 0.04% | +18.9% |
| Q1 2018 | $124,000 | -7.5% | 3,500 | 0.0% | 0.04% | -14.0% |
| Q4 2017 | $134,000 | +45.7% | 3,500 | 0.0% | 0.04% | +38.7% |
| Q3 2017 | $92,000 | +43.8% | 3,500 | 0.0% | 0.03% | +24.0% |
| Q2 2017 | $64,000 | – | 3,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |